$4.85
0.449.98%
Last update: Jul 18, 8:32 AM
15 minutes delayed
Comments
Loading...
Lantern Pharma
LTRNNASDAQ
Lantern Pharma (LTRN) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestLantern Pharma (NASDAQ:LTRN) Stock Quotes, Forecast and News Summary
Lantern Pharma Stock (NASDAQ: LTRN) stock price, news, charts, stock research, profile.
| Open | $4.49 |
| Close | - |
| Volume / Avg. | 22.99K / 95.76K |
| Day Range | 4.38 - 4.53 |
| 52 Wk Range | 2.38 - 11.99 |
| Market Cap | $52.18M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 45 |
| Short Interest | 3.27% |
| Days to Cover | 3.31 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Lantern Pharma Inc
Sector
Health Care
Industry
Biotechnology
Lantern Pharma is an AI company transforming the cost, pace, and timeline of oncology drug discovery...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Lantern Pharma (LTRN) stock?
You can purchase shares of Lantern Pharma (NASDAQ:LTRN) through any online brokerage.
Who are Lantern Pharma (LTRN) competitors?
Other companies in Lantern Pharma’s space includes: Kezar Life Sciences (NASDAQ:KZR), Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), OncoCyte (NASDAQ:OCX) and CARISMA Therapeutics (NASDAQ:CARM).
What is the target price for Lantern Pharma (LTRN) stock?
There is no analysis for Lantern Pharma.
What is the forecast for Lantern Pharma (LTRN) stock?
Lantern Pharma has a consensus price target of $11.00.
Current stock price for Lantern Pharma (LTRN)?
The stock price for Lantern Pharma (NASDAQ: LTRN) is $4.85 last updated July 18, 2024 at 8:32 AM EDT.
Does Lantern Pharma (LTRN) pay a dividend?
There are no upcoming dividends for Lantern Pharma.
When is Lantern Pharma (NASDAQ:LTRN) reporting earnings?
Lantern Pharma’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
Is Lantern Pharma (LTRN) going to split?
There is no upcoming split for Lantern Pharma.
What sector and industry does Lantern Pharma (LTRN) operate in?
Lantern Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.